Original development by REGER – directly for trade and market
The demand for modern therapeutic methods for treating peritoneal metastases is growing—and with it the need for specialized medical technology for PIPAC (Pressurized IntraPeritoneal Aerosol Chemotherapy).
With REGER’s PIPAC systems, dealers and distribution partners can expand their portfolio with future-oriented, MDR-compliant solutions for surgical oncology and laparoscopic procedures.
As a distribution partner, you benefit from high-quality products, clear documentation, and a strong brand that has been working with leading PIPAC centers for years.
Why PIPAC from REGER strengthens your portfolio
REGER has been synonymous with the development and establishment of PIPAC technology for many years and has extensive experience in a highly specialized medical field. As the original manufacturer, REGER supports its trading partners far beyond the product itself—providing technical, strategic, and market-oriented assistance.
REGER’s PIPAC systems have been specifically designed to meet the requirements of intraperitoneal aerosol chemotherapy and combine technological excellence with regulatory safety:
- Reliable and reproducible aerosol delivery for standardized clinical procedures
- Robust, surgical-grade system solutions for daily use
- MDR Class IIb certification as the basis for maximum regulatory safety
- Developed and manufactured in Germany – a promise of quality that clinics and users trust
In addition, REGER supports its distribution partners with ongoing expert advice, high-quality marketing and training materials, and practical workshops. These formats offer dealers the opportunity to work with doctors and clinical users to develop a deep understanding of the product and its applications, and to position PIPAC firmly in the market.
With REGER, you can tap into a growing, clearly defined market segment: specialized clinics, university centers, and oncology departments that use PIPAC as an integral part of multimodal therapy concepts.
MDR-compliant medical technology: Safety for you and your customers
Regulatory requirements are becoming increasingly complex in medical technology distribution. With REGER, you have a partner who:
- Provides MDR Class IIb-compliant products
- Provides technical and clinical documentation
- Supported during registration processes
- Provides clearly structured information for purchasing departments and QM teams
This allows you to provide your customers with all relevant information quickly, transparently, and in a legally compliant manner.
The benchmark in PIPAC development
Reger stands for progress in PIPAC technology like no other name. Extensive studies confirm the clinical value of the procedure and reflect the intensive development work that has gone into it. With its deep understanding of the process and continuous innovation, Reger maintains its position as a leading developer and driving force in the field of PIPAC.
Product portfolio: PIPAC nebulizers and accessories
With REGER systems, you can offer a coherent product portfolio for PIPAC therapy. The products are designed to be easily integrated into existing procurement and surgical structures.
- PIPAC nebulizer for aerosol application in the abdominal cavity
- Compatible components and accessories for laparoscopic applications
- QuattroJet® technology with multidirectional distribution for homogeneous aerosol clouds
- Solutions for integration into existing operating room setups
Benefits for sales partners and medical technology distributors
As a REGER sales partner, you benefit from:
Your target customers: Where REGER PIPAC systems are used
PIPAC systems from REGER are particularly interesting for:
- University hospitals
- Centers for Visceral Surgery and Oncology
- Gynecological Oncology Centers
- Specialized peritoneal carcinomatosis centers
- Clinics that want to expand their portfolio to include PIPAC as a supplement to systemic chemotherapy and/or HIPEC
Sales with prospects: growth through specialization
The combination of increasing clinical experience, growing awareness of PIPAC therapy, and clearly defined indications ensures that PIPAC systems will remain a permanently relevant segment.
As a distributor, you are positioning yourself early on in a field that combines technology, evidence-based medicine, and highly specialized users.
Daniel Seemann
Sales Manager
E-Mail: d.seemann@reger-med.de
Phone: +49 176 4332 8487